Search for stocks /

ROX Hi-Tech Limited H1FY26 Concall Decoded: ₹111 Cr topline, margins blink first, ambition doesn’t


1. Opening Hook

Another SME IT stock, another “global expansion + AI + cloud” presentation — because apparently 2025 came with a mandatory buzzword checklist. ROX Hi-Tech showed up with SAP, Cisco, IBM, AI, RPA, medical automation, four overseas subsidiaries, and a Network Operations Center thrown in for good measure.

Revenue sprinted ahead, EBITDA tripped slightly, and cash flows decided to freestyle. Management sounded confident, expansion-hungry, and very excited about Agentic AI — the kind of excitement that usually arrives just before margins are asked to “adjust temporarily.”

If you’re here only for topline growth, congratulations — you’ll be thrilled. If you care about working capital, cash flow discipline, and margin durability, keep reading. Things get far more interesting once the numbers stop smiling.


2. At a Glance

  • Revenue up 31% YoY (H1) – Growth engine firing; fuel bill quietly rising.
  • EBITDA down 10% – Same race car, heavier luggage.
  • EBITDA margin fell to 15% – From premium to mid-range, real quick.
  • PAT flat at ₹10.2 Cr – Profit chose stability over ambition.
  • Cash flow negative (Ops) – Accounting profits, real cash went on vacation.
  • Stock ~58% below highs – Market heard the story, then read the footnotes.

3. Management’s Key Commentary

“We are a one-stop shop from cable to cloud.”
(Translation: We do everything — integration complexity included.) 😏

“Our SAP and IBM partnerships differentiate us.”
(Translation: Vendor logos still do the heavy lifting.)

“We successfully implemented RISE with SAP ahead of peers.”
(Translation: Execution capability is real, not PowerPoint.)

“Agentic AI is a major growth driver.”
(Translation: AI is the new ERP pitch deck.) 🤖

“Global subsidiaries will open new revenue streams.”
(Translation: Costs first, revenues later.)

“NOC and SOC are operational with clients onboarded.”
(Translation: Recurring revenue potential — if scale follows.)

“Medical automation platform beta is imminent.”
(Translation: Great idea, commercial proof still pending.)


4. Numbers Decoded

MetricH1 FY25H1 FY26What Changed
Revenue (₹ Cr)84.8111.0Strong execution, deal flow intact
EBITDA
Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!